Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDekel Agri Regulatory News (DKL)

Share Price Information for Dekel Agri (DKL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.15
Bid: 1.10
Ask: 1.20
Change: 0.00 (0.00%)
Spread: 0.10 (9.091%)
Open: 1.15
High: 1.15
Low: 1.15
Prev. Close: 1.15
DKL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

16 Sep 2014 07:00

RNS Number : 7346R
Dekeloil Public Limited
16 September 2014
 



DekelOil Public Limited / Index: AIM / Epic: DKL/ ISIN: CY0103462210 / Sector: Food Producers

 16 September 2014

DekelOil Public Limited ('DekelOil' or 'the Company')

Interims Results

 

DekelOil Public Limited, a palm oil development company with interests in Côte d'Ivoire, is pleased to announce its interim results for the year ended 30 June 2014.

 

Highlights

 

· DekelOil successfully established as a revenue-generative, EBITDA-positive vertically-integrated CPO producer in the Cote d'Ivoire

· Successful commissioning of a 60 tonne per hour mill, one of the largest in West Africa, in March 2014 - operational for four months of the period

· Revenues of €4.5m and EBITDA of €0.3m reported for the 6 month period

· Implementation of a solid logistics strategy which facilitates delivery of smallholder feedstock to the Mill - logistics hubs will be established on an on-going basis

· Production for the first half of operations to June 2014 stood at 7,932 tonnes of CPO and 1,311 tonnes of kernels

· Two further off-take agreements with domestic customers - the Company now has three in place in line with its strategy to secure a diversified, local sales book

· Successfully executing strategy to increase its institutional shareholder base

· Operating in a highly dynamic corporate environment - West Africa continues to attract the attention of major palm oil developers looking to secure future expansion

· Strongly placed for growth with a defined growth strategy in place

 

DekelOil Executive Director Lincoln Moore said, "The first six months of the year have been highly fruitful for DekelOil and I am pleased to report that we met our key objectives during the period. Considering that the Mill was only operational for four months of this half year period, we are very pleased with the revenue and EBITDA reported and we look forward to building on this. We have a defined growth strategy focussed on increasing our production and planted land position. We are operating in a highly dynamic sector, and look forward to maximising our value in the coming months and beyond."

 

For further information please visit the Company's website www.dekeloil.com or contact:

 

Youval Rasin

 

DekelOil Public Limited

 

Tel: +44 (0) 20 7024 8391

Shai Kol

Lincoln Moore

Andrew Craig

Ben Wright

Nplus1 Singer Advisory LLP

 

Tel: +44 (0) 20 7496 3000

Christian Dennis Jeremy King

Elisabeth Cowell

Optiva Securities Limited

 

Tel: +44 (0) 20 3137 1903

 

Frank Buhagiar

St Brides Media & Finance Ltd

Tel: +44 (0) 20 7236 1177

CHAIRMAN'S STATEMENT

 

DekelOil is focussed on becoming a leading crude palm oil ('CPO') producer in West Africa and I am pleased to report that we have made significant strides towards this goal by establishing ourselves as a revenue-generative, EBITDA-positive vertically-integrated CPO producer in the Cote d'Ivoire.

 

A key component of our success during the period was the commissioning of our first 70,000 tonne per annum ('tpa') extraction mill ('the Mill') at the Ayenouan Project in March, one of the largest in West Africa, on time and on budget.

 

Much of the production at the Ayenouan project is currently derived from smallholders. The 1,900ha of Company-owned plantations are now entering the mature phase and will be a growing source of Fresh Fruit Bunches ('FFB') in 2015. Smallholder production will not be displaced but rather delivered in addition to our own FFB. Accordingly, the implementation of a highly functional logistics strategy is crucial and we have experienced success with this during the period. In order to ensure that FFBs are delivered in a timely manner and to negate queuing at the Mill, we have established two logistics hubs to date in the area surrounding the project in addition to the FFB reception facility at the Mill.

 

These hubs have already proved effective, and our July production update highlighted that production for the Mill's first full quarter of operations and our total production from March to June stood at 7,932 tonnes of CPO and 1,311 tonnes of kernels. The monthly average production for the April to June period increased substantially in comparison to that for March 2014 in which 1,617 tonnes of CPO were produced, the Company's first month of full production. It also highlighted how the Mill's initial production fundamentals are in line with the Board's expectations, with CPO production extracted at a rate above 23% up from 21% in March.

 

With the Mill operating well and FFB supply increasing, the Board is confident that our production in 2015 will grow substantially. In terms of sales, we have secured a diversified customer base by way of three off-take agreements with domestic customers. By having a range of buyers for our product, not only do we de-risk our sales strategy and commercialise our assets, but we also benefit from lower transportation costs.

 

In summary, we have delivered on our key objectives for the period under review. Accordingly, despite the Mill being only operational for four months of the period, we are reporting EBITDA of €0.3 million for the six month period. Our strategy, and its effective implementation has attracted institutions to the shareholder register and in February 2014, we were delighted to welcome Nubuke as a shareholder and we look forward to bolstering this institutional representation further.

 

Our achievements during the past 12 months have provided a strong platform to realise further growth and we will seek to continue to develop our relationships with smallholders to increase yields from their plantations as we come into the key harvesting season. The low harvest season runs from July to September and while we expect our production rate to be inherently lower during this period, we are using this time to identify sites for two further logistics hubs. Following site identification, the establishment of hub sites takes two-three months with capital expenditure of less than €100,000 per hub.

 

Looking ahead of this, subject to available finances, we plan to fast-track our planting programme to develop a further 3,000 to 5,000 ha of company-owned plantations in close proximity to the Mill in the mid-term. In addition, we are assessing the option to construct a palm kernel crushing facility which we believe would further enhance the project's margins.

 

Our second project area in Cote d'Ivoire, Guitry, provides us with a path to significantly scale our business in the mid to longer term. This site consists of 24,000 hectares of brownfield land suitable for planting and once we have unlocked and maximised the value of our current project area, we plan to further penetrate the West African palm oil market by way of development of this site.

 

Increasing our footprint in the region is a particularly important objective for the Company given the current trends evident across the palm oil sector. As land becomes increasingly difficult to obtain in Indonesia and Malaysia for a variety of reasons, West Africa continues to attract the attention of major palm oil developers looking to secure their future expansion in the industry due to the suitability of the climate, and the agricultural environment. Demand for CPO is estimated to double by 2020 and with this in mind, four of the world's largest palm oil companies; Wilmar, Sime Darby, KLK and Golden Agri, have entered West Africa. Several noteworthy transactions have been undertaken across the sector in recent months and notably, despite being one of the most advanced junior CPO producers in the region, DekelOil is currently one of the only established, palm oil developers not in partnership with a major Asian palm oil company.

 

Our ambitions are not limited to Cote d'Ivoire alone, and we continually evaluate land packages in additional West African countries, including neighbouring Ghana. We will naturally provide updates on this at the appropriate time.

 

Financial Review

 

As mentioned previously, the Mill was operational for four months during the first half of the year, which generated revenues of €4,505,000 for the Company (2013: nil). We are pleased to have achieved an EBITDA of €0.3 million. The loss before tax on income was €761,000.

 

Outlook

 

It is my strong belief that DekelOil is ideally poised for further growth. We have 51% of a profitable, vertically integrated palm oil project in the Cote d'Ivoire which is generating material revenues; a defined strategy; land package for ongoing growth; and a highly experienced management team with which to drive the Company forward. Add to this the demand for our product on both a local and global level, and it is easy to understand the highly attractive economics of our asset base.

 

I would like to take this opportunity to thank shareholders for their support and I look forward to providing further announcements in the near term as we deliver increasing production, and hit a range of further milestones in the coming months and beyond.

 

Andrew Tillery

 

Non Executive Chairman

 

 

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

 

30 June

31 December

2014

2013

Unaudited

Audited

Euros in thousands

ASSETS

CURRENT ASSETS:

Cash and cash equivalents

639

1,117

Trade receivables

393

-

Inventory

917

-

Government authorities and accounts receivable

269

489

Total current assets

2,218

1,606

NON-CURRENT ASSETS:

Long-term deposits

115

132

Biological assets

6,992

6,645

Property and equipment, net

19,149

16,285

Total non-current assets

26,256

23,062

Total assets

28,474

24,668

CURRENT LIABILITIES:

Trade payables

826

386

Short-term loans and current maturities of long-term loans

3,038

977

Advance payments from customers

942

637

Other accounts payable and accrued expenses

505

435

Total current liabilities

5,311

2,435

NON-CURRENT LIABILITIES:

Long-term capital lease

22

24

Accrued severance pay, net

38

33

Long-term loan

12,278

12,346

Capital notes and other liabilities

6,005

5,667

Financial liability for warrants

380

275

Total non-current liabilities

18,723

18,345

Total liabilities

24,034

20,780

EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY

1,321

1,029

Non-controlling interests

3,119

2,859

Total equity

4,440

3,888

Total liabilities and equity

28,474

24,668

 

CONSOLIDATED STATEMENTS OF INCOME

 

 

Six months ended

30 June

Six months ended

30 June

 

Year ended

31 December

2014

2013

2013

Unaudited

Unaudited

Audited

Euros in thousands (except share and per share amounts)

Revenues

4,505

201

465

Net gain from changes in fair value of biological assets

439

363

1,429

Operating expenses

(3,551)

(224)

(429)

General and administrative

(1,242)

(1,055)

(2,209)

Profit (loss) before financing costs

151

(715)

(744)

Finance cost

(912)

(362)

(723)

Loss before taxes on income

(761)

(1,077)

(1,467)

Taxes on income

(3)

(6)

(6)

Net loss

(764)

(1,083)

(1,473)

Attributable to:

Equity holders of the Company

(570)

(675)

(1,013)

Non-controlling interests

(194)

(408)

(460)

Net loss

(764)

(1,083)

(1,473)

Net loss per share attributable to equity holders of the Company (in Euros):

Basic and diluted loss per share in Euros

0.00

0.00

0.00

 

 

 

 

 

 

 

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

 

 

 

Six months ended

30 June

Six months ended

30 June

 

Year ended

31 December

2014

2013

2013

Unaudited

Unaudited

Audited

Euros in thousands

Net loss

(764)

(1,083)

(1,473)

Other comprehensive loss:

Amounts that will not be reclassified subsequently to profit or loss:

Actuarial gains on defined benefit plans

-

-

(12)

Total comprehensive loss

(764)

(1,083)

(1,485)

Total comprehensive loss attributable to:

Equity holders of the Company

(570)

(675)

(1,025)

Non-controlling interests

(194)

(408)

(460)

(764)

(1,083)

(1,485)

 

 

 

 

 

 

 

The accompanying notes are an integral part of the interim consolidated financial statements.

 

 

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

 

Attributable to equity holders of the Company

Share capital

Additional paid-in capital

Accumulated deficit

Capital reserve

Capital reserve from transactions with non-controlling interests

Total

Non-controlling interests

Total

equity

Euros in thousands

Balance as of 1 January 2013 (audited)

26

875

(7,746)

2,532

3,175

(1,138)

1,332

194

Net loss

-

-

(1,013)

-

-

(1,013)

(460)

(1,473)

Actuarial loss

-

-

(12)

-

-

(12)

-

(12)

Total after comprehensive loss

-

-

(1,025)

-

-

(1,025)

(460)

(1,485)

Capital contribution to subsidiary by non-controlling interests

-

-

-

-

-

-

1,972

1,972

Conversion of capital notes to equity

3

1,114

-

-

-

1,117

-

1,117

Issuance of shares upon IPO, net of issuance cost

15

1,996

-

-

-

2,011

-

2,011

Share-based compensation

-

64

-

-

-

64

-

64

Balance as of 31 December 2013 (audited)

44

4,049

(8,771)

2,532

3,175

1,029

2,844

3,888

Net loss

-

-

(570)

-

-

(570)

(194)

(764)

Issuance of shares, net

2

828

-

-

-

830

-

830

Capital contribution to subsidiary by non-controlling interests

-

-

-

-

-

-

469

469

Share-based compensation

-

32

-

-

-

32

-

32

Balance as of 30 June 2014 (unaudited)

46

4,909

(9,341)

2,532

3,175

1,321

3,119

4,440

 

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

Attributable to equity holders of the Company

Share capital

Additional paid-in capital

Accumulated deficit

Capital reserve

Capital reserve from transactions with non-controlling interests

Total

Non-controlling interests

Total

equity

Euros in thousands

Balance as of 1 January 2013 (audited)

26

875

(7,746)

2,532

3,175

(1,138)

1,332

194

Net loss

-

-

(675)

-

-

(675)

(408)

(1,083)

Issuance of shares upon IPO, net of issuance costs

17

2,048

-

-

-

2,065

-

2,065

Share-based compensation

-

16

-

-

-

16

-

16

Conversion of capital notes to equity

2

982

-

-

-

984

-

984

Balance as of 30 June 2013 (unaudited)

45

3,921

(8,421)

2,532

3,175

1,252

924

2,176

 

The accompanying notes are an integral part of the interim consolidated financial statements.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

Six months ended

30 June

Six months ended

30 June

 

Year ended

31 December

2014

2013

2013

Unaudited

Unaudited

Audited

Euros in thousands

Cash flows from operating activities:

Net loss

(764)

(1,083)

(1,473)

Adjustments to reconcile net loss to net cash provided by (used in) in operating activities:

 Adjustments to the profit or loss items:

Depreciation and amortization

187

54

93

Share-based compensation

32

16

64

Accrued interest on long-term loan and non-current liabilities

527

333

1,633

Change in employee benefit liabilities, net

5

1

(3)

Gain from changes in fair value of biological assets

(439)

(363)

(1,429)

Changes in asset and liability items:

Increase in trade receivables

(393)

-

-

 Increase in inventory

(917)

-

-

Decrease (increase) in Government authorities and accounts receivable

220

(440)

(425)

Increase in trade payables

440

441

148

Increase in advance from costumers

305

-

637

Increase in financial liability for warrants

105

-

-

Increase in accrued expenses and other accounts payable

70

656

180

142

698

898

Cash paid during the year for:

Interest

(448)

-

(400)

Cash paid during the year for:

Tax

-

(6)

(6)

Net cash used in operating activities

(1,070)

(391)

(981)

 

 

The accompanying notes are an integral part of the interim consolidated financial statements.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

Six months ended

30 June

Six months ended

30 June

 

Year ended

31 December

2014

2013

2013

Unaudited

Unaudited

Audited

Euros in thousands

Long-term deposits

17

19

(96)

Investment in biological assets

-

(44)

(198)

Purchase of property and equipment

(2,734)

(5,429)

(10,968)

Net cash used in investing activities

(2,717)

(5,454)

(11,262)

Cash flows from financing activities:

Issuance of shares, net

830

2,065

2,011

Capital contribution to subsidiary from non-controlling interests

469

-

1,972

Receipt of short-term loan, net

396

280

-

Receipt of long-term loans

1,616

3,839

9,267

Payment of long-term capital lease

(2)

-

(14)

Net cash provided by financing activities

3,309

6,184

13,236

Increase (decrease) in cash and cash equivalents

(478)

339

993

Cash and cash equivalents at beginning of period

1,117

124

124

Cash and cash equivalents at end of period

639

463

1,117

 

(a)

Supplemental disclosure of non-cash financing activities:

Conversion of capital notes to warrants and shares

-

984

1,378

 

The accompanying notes are an integral part of the interim consolidated financial statements.

 

NOTE 1:- GENERAL

 

a. DekelOil Public Limited ("the Company") is a public limited company incorporated in Cyprus on 24 October 2007. The Company is engaged through its subsidiaries in developing and cultivating palm oil plantations in Cote d'Ivoire and the processing, production and marketing of Crude Palm Oil ("CPO"). The Company's registered office is in Limassol, Cyprus.

 

b. As of 30 June 2014, the Company has a working capital deficiency of Euro 3,093 thousand.

During the six months ended 30 June 2014 the Company incurred a net loss of Euro 674

thousands and has negative cash flows from operations of Euro 1,070 thousands.

 

In 2014 the Company completed the construction of its palm oil extraction mill and commenced production and sale of palm oil. The mill is presently generating positive cash flows from its operations and Company's management expects the positive cash flows to grow as the mill increases its production capacity. However, as this is the first year of the mill's operations, there is no certainty that the mill will be able to meet the Company's projections as to increased production and positive cash flows from such production. Furthermore, the operations of the mill are subject to various market conditions that are not under the Company's control that could have an adverse effect on the Company's cash flows.

Based on the aforementioned, the Company management believes that it will have sufficient funds necessary to finance its operations and meet its obligations as they

come due at least for the next twelve months from the date the financial statements are approved.

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES

 

a. Basis of preparation:

 

The interim condensed financial statements as of 30 June, 2014 and for the six months then ended have been prepared in accordance with IAS 34, "Interim Financial Reporting", as adopted by the European Union.

The interim condensed financial statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Company's annual financial statements as of 31 December, 2013 and their accompanying notes.

 

b. Accounting policies:

 

The accounting policies adopted in the preparation of the interim condensed financial statements are consistent with those followed in the preparation of the Company's annual financial statements for the year ended 31 December, 2013.

 

c. Inventories:

 

Inventories are measured at the lower of cost and net realizable value.

 

 

Cost is determined using the "first in first out" method.

 

c. Disclosure of new standards in the period prior to their adoption:

 

1. IFRS 9, "Financial Instruments":

 

In keeping with the matters discussed in Note 4 to the annual financial statements as of December 31, 2013 regarding disclosure of new IFRS Standards in the period prior to their adoption in the issue of IFRS 9, in July 2014, the IASB issued the final and complete version of IFRS 9, "Financial Instruments" ("the final Standard") which includes the following elements: classification and measurement, impairment and hedge accounting.

The main changes between the final Standard and the previously published phases of the Standard are:

Classification and measurement:

The final version of IFRS 9 includes another category for the classification and measurement of financial assets that represent debt instruments. Financial assets classified in this category will be measured at fair value through other comprehensive income ("FVOCI") and the differences previously carried to other comprehensive income as above will be reclassified to profit or loss under specific conditions such as when the asset is derecognized.

Impairment:

The final Standard addresses the issue of impairment of financial assets by introducing the expected credit loss impairment model to replace the incurred loss model prescribed in IAS 39. The expected credit loss model applies to debt instruments measured at amortized cost or at FVOCI and to trade receivables.

 

The Company is presently evaluating the impact, if any, of IFRS 9 on the financial statements.

 

2. Amendments to IAS 16 and IAS 41, "Agriculture: Bearer Plants":

 

In June 2014, the IASB issued amendments to IAS 16, Property, Plant and Equipment, and IAS 41, Agriculture, in respect of the accounting treatment for bearer plants. The amendments define bearer plants as a living plant that is used in the production or supply of agricultural produce, is expected to bear produce for more than one period and has a remote likelihood of being sold as agricultural produce, except for incidental scrap sales. The amendments require bearer plants to be accounted for as plant, property and equipment, and included within the scope of IAS 16. Accordingly, before maturity, bearer plants will be measured at their accumulated cost. After maturity, entities will have a policy choice to measure bearer plants using either the cost model or the revaluation model. Prior to the amendments, bearer plants were included within the scope of IAS 41 and measured at fair value less costs to sell. The produce growing on bearer plants will remain in the scope of IAS 41.

The Company is evaluating the possible impact of the amendments but is presently unable to assess their effect, if any, on the financial statements.

 

d. Fair value of financial instruments:

 

The Company's financial instruments that are presented in the financial statements not at fair value approximate their carrying amount.

 

 

NOTE 3:- SIGNIFICANT EVENTS DURING THE PERIOD

 

a. In March 2014 a subsidiary of the Company completed construction of its palm oil extraction mill and started commercial production.

 

b. On 24 February 2014 the Company raised £700,000 (approximately Euro 830 thousand) by way of placing 46,666,666 new ordinary shares at a price of 1.5 pence per share.

An amount of Euro 500 thousand was invested in CS DekelOil Siva and Biopalm Energy Ltd matched this investment by investing an additional Euro 469 thousand.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR GMGMLVKZGDZM
Date   Source Headline
28th Jun 20245:26 pmRNS2023 Final Results and Financing Update
10th Jun 20247:00 amRNSMay Palm Oil Production Update
10th May 20247:00 amRNSApril Palm Oil Production Update
15th Apr 20249:10 amRNSDirector dealing / PDMR shareholding
11th Apr 20247:00 amRNSQ1 2024 Palm Oil and Cashew Operations Update
12th Mar 20241:51 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSFebruary Palm Oil Production & Issue of Equity
21st Feb 20241:05 pmRNSHolding(s) in Company
13th Feb 20247:00 amRNSJanuary Palm Oil Production Update
11th Jan 20247:00 amRNSFull Year 2023 Operational Update
11th Dec 20237:00 amRNSRecord November Palm Oil Production Update
10th Nov 20237:00 amRNSOctober Palm Oil Production Update
11th Oct 202311:45 amRNSInvestor Presentation and Call
10th Oct 20237:00 amRNSSeptember Palm Oil & Q3 Cashew Operation Update
28th Sep 20238:00 amRNSIssue of Equity
28th Sep 20237:00 amRNS2023 Interim Results
8th Sep 20237:00 amRNSAugust Palm Oil Production Update
24th Aug 20237:00 amRNSCashew Operation Update
10th Aug 20237:00 amRNSJuly Palm Oil Production Update
27th Jul 202310:57 amRNSResult of AGM
12th Jul 20237:00 amRNSHalf Year Operational Update
28th Jun 20237:00 amRNS2022 Final Results and AGM
23rd Jun 20237:00 amRNSLoan Facility– Fixed Interest Rate Agreed
12th Jun 20237:00 amRNSMay Palm Oil Production Update
10th May 20237:00 amRNSApril Palm Oil Production Update
20th Apr 20237:00 amRNSQ1 2023 Cashew Operation Update
11th Apr 20237:00 amRNSMarch Palm Oil Production Update
13th Mar 20237:01 amRNSDirector Shareholding and Issue of Equity
13th Mar 20237:00 amRNSFebruary Palm Oil and Cashew Operation Update
14th Feb 20237:00 amRNSJanuary Palm Oil and Cashew Operation Update
24th Jan 20237:00 amRNSIncreased acquisition of Cashew Operation to 100%
10th Jan 20237:00 amRNSFull Year 2022 Palm Oil Production Update
9th Dec 20227:00 amRNSNovember Palm Oil & Cashew Operation Update
10th Nov 20227:00 amRNSOctober Palm Oil & Cashew Operation Update
10th Oct 20227:00 amRNSSeptember Palm Oil & Cashew Operation Update
28th Sep 202210:53 amRNSInvestor Presentation Reschedule
22nd Sep 20227:00 amRNSInterim Results and Investor Presentation
12th Sep 20227:00 amRNSAugust Palm Oil Production & Cashew Project Update
16th Aug 20227:00 amRNSBond Facility Use of Proceeds Update
10th Aug 20227:00 amRNSJuly Palm Oil Production & Cashew Project Update
28th Jul 20227:00 amRNSCashew Operation Update
26th Jul 202212:23 pmRNSResult of AGM
26th Jul 20227:00 amRNSAGM Statement
25th Jul 20227:00 amRNSFinal Bond Facility Drawdown on Improved Terms
22nd Jul 20223:49 pmRNSTR1: Notification of Major Holdings
20th Jul 20223:15 pmRNSCompletion of Nominated Adviser Due Diligence
11th Jul 20227:00 amRNSH1 2022 Operating Update
23rd Jun 20227:00 amRNS2021 Final Results
13th Jun 20227:00 amRNSMay Palm Oil Production & Cashew Project Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.